| 1 | Senescent cell transplantation into the skin induces age‐related peripheral dysfunction and cognitive decline | 6.8 | 28 | Citations (PDF) |
| 2 | Mapping epidermal and dermal cellular senescence in human skin aging | 6.8 | 28 | Citations (PDF) |
| 3 | The Complex Interplay of Sex Steroids and Sex Hormone–Binding Globulin in Determining Fracture Risk in Men | 4.0 | 3 | Citations (PDF) |
| 4 | Characterization of Human Senescent Cell Biomarkers for Clinical Trials | 6.8 | 14 | Citations (PDF) |
| 5 | Biomarkers of Cellular Senescence in Type 2 Diabetes Mellitus | 6.8 | 6 | Citations (PDF) |
| 6 | Calorie restriction reduces biomarkers of cellular senescence in humans | 6.8 | 57 | Citations (PDF) |
| 7 | Senotherapeutic drug treatment ameliorates chemotherapy-induced cachexia | 5.4 | 34 | Citations (PDF) |
| 8 | Vertebral Fracture Risk Thresholds from Phantom-Less Quantitative Computed Tomography-Based Finite Element Modeling Correlate to Phantom-Based Outcomes | 1.1 | 3 | Citations (PDF) |
| 9 | Senescent skeletal muscle fibroadipogenic progenitors recruit and promote M2 polarization of macrophages | 6.8 | 31 | Citations (PDF) |
| 10 | Fracture Risk Among Living Kidney Donors 25 Years After Donation | 6.6 | 7 | Citations (PDF) |
| 11 | Transitions - Sundeep Khosla, M.D., Editor-In-Chief for Bone, 2013-2023 | 3.4 | 0 | Citations (PDF) |
| 12 | Osteochondroprogenitor cells and neutrophils expressing p21 and senescence markers modulate fracture repair | 10.6 | 30 | Citations (PDF) |
| 13 | Persistent changes in calcium-regulating hormones and bone turnover markers in living kidney donors more than 20 years after donation | 2.0 | 1 | Citations (PDF) |
| 14 | Marrow Adipocyte Senescence in the Pathogenesis of Bone Loss | 4.6 | 6 | Citations (PDF) |
| 15 | SenNet recommendations for detecting senescent cells in different tissues | 78.1 | 314 | Citations (PDF) |
| 16 | Hdac3-deficiency increases senescence-associated distention of satellite DNA and telomere-associated foci in osteoprogenitor cells | 4.9 | 7 | Citations (PDF) |
| 17 | Osteoporosis treatment prevents hip fracture similarly in both sexes: the FOCUS observational study | 4.9 | 16 | Citations (PDF) |
| 18 | Response to the editor of JBMR regarding the letter related to “Opportunistic screening with CT: comparison of phantomless BMD calibration methods” | 4.9 | 0 | Citations (PDF) |
| 19 | Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial | 33.0 | 89 | Citations (PDF) |
| 20 | Isolation and characterization of bone mesenchymal cell small extracellular vesicles using a novel mouse model | 4.9 | 10 | Citations (PDF) |
| 21 | 6612 Both Overt And Mild Hypercortisolism Accelerate Biological Aging | 0.3 | 0 | Citations (PDF) |
| 22 | Osteoporosis in the USA: prevention and unmet needs | 21.7 | 19 | Citations (PDF) |
| 23 | Local senolysis in aged mice only partially replicates the benefits of systemic senolysis | 10.6 | 72 | Citations (PDF) |
| 24 | MicroRNA
‐
19a
‐
3p
Decreases with Age in Mice and Humans and Inhibits Osteoblast Senescence | 2.0 | 15 | Citations (PDF) |
| 25 | Mapping cellular senescence networks in human diabetic foot ulcers | 4.6 | 20 | Citations (PDF) |
| 26 | A Fracture Risk Assessment Tool for High Resolution Peripheral Quantitative Computed Tomography | 4.9 | 43 | Citations (PDF) |
| 27 | Validating the Fracture Risk Assessment Tool Score in a US Population-Based Study of Patients With Rheumatoid Arthritis | 2.3 | 12 | Citations (PDF) |
| 28 | Single‐Cell Integration of
BMD GWAS
Results Prioritize Candidate Genes Influencing Age‐Related Bone Loss | 2.0 | 6 | Citations (PDF) |
| 29 | Modest Effects of
Osteoclast‐Specific ERα
Deletion after Skeletal Maturity | 2.0 | 2 | Citations (PDF) |
| 30 | Evidence in humans for bone as an endocrine organ regulating energy metabolism | 1.0 | 5 | Citations (PDF) |
| 31 | Multiparametric senescent cell phenotyping reveals targets of senolytic therapy in the aged murine skeleton | 13.7 | 52 | Citations (PDF) |
| 32 | Apoptotic stress causes mtDNA release during senescence and drives the SASP | 37.9 | 568 | Citations (PDF) |
| 33 | Influences of Aged Bone Marrow Macrophages on Skeletal Health and Senescence | 4.6 | 14 | Citations (PDF) |
| 34 | Opportunistic Screening With CT: Comparison of Phantomless BMD Calibration Methods | 4.9 | 25 | Citations (PDF) |
| 35 | THU605 Impact Of Abnormal Circadian Cortisol Secretion On Bone Metabolism In Patients With Mild Autonomous Cortisol Secretion | 0.3 | 0 | Citations (PDF) |
| 36 | Vertebral Fracture Risk Is Increased Among Living Kidney Donors 25 Years After Donation: Survey-Based Study | 0.4 | 0 | Citations (PDF) |
| 37 | Validation of the Surrogate Threshold Effect for Change in Bone Mineral Density as a Surrogate Endpoint for Fracture Outcomes: The FNIH-ASBMR SABRE Project | 4.9 | 63 | Citations (PDF) |
| 38 | Bone Microarchitecture Phenotypes Identified in Older Adults Are Associated With Different Levels of Osteoporotic Fracture Risk | 4.9 | 55 | Citations (PDF) |
| 39 | Cellular senescence and the skeleton: pathophysiology and therapeutic implications | 10.6 | 87 | Citations (PDF) |
| 40 | Fracture Healing in the Setting of Endocrine Diseases, Aging, and Cellular Senescence | 24.6 | 156 | Citations (PDF) |
| 41 | Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans | 9.7 | 85 | Citations (PDF) |
| 42 | Bone Marrow Adiposity in Models of Radiation- and Aging-Related Bone Loss Is Dependent on Cellular Senescence | 4.9 | 41 | Citations (PDF) |
| 43 | Targeted clearance of p21‐ but not p16‐positive senescent cells prevents radiation‐induced osteoporosis and increased marrow adiposity | 6.8 | 109 | Citations (PDF) |
| 44 | The crosstalk between bone remodeling and energy metabolism: A translational perspective | 25.2 | 100 | Citations (PDF) |
| 45 | Skeletal Aging | 3.7 | 94 | Citations (PDF) |
| 46 | Effects of diabetes on osteocytes | 2.2 | 25 | Citations (PDF) |
| 47 | Identification of a suitable endogenous control miRNA in bone aging and senescence | 2.3 | 17 | Citations (PDF) |
| 48 | Characterization of cellular senescence in aging skeletal muscle | 14.5 | 186 | Citations (PDF) |
| 49 | Skeletal Effects of Inducible ERα Deletion in Osteocytes in Adult Mice | 4.9 | 16 | Citations (PDF) |
| 50 | Guanylyl Cyclase-B Dependent Bone Formation in Mice is Associated with Youth, Increased Osteoblasts, and Decreased Osteoclasts | 2.8 | 5 | Citations (PDF) |
| 51 | A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues | 13.7 | 882 | Citations (PDF) |
| 52 | Establishment of normative biometric data for body composition based on computed tomography in a North American cohort | 5.3 | 7 | Citations (PDF) |
| 53 | Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span | 11.8 | 303 | Citations (PDF) |
| 54 | Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction | 2.2 | 168 | Citations (PDF) |
| 55 | Senescent cells exacerbate chronic inflammation and contribute to periodontal disease progression in old mice | 3.6 | 70 | Citations (PDF) |
| 56 | Treatment-Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Antiresorptive Drugs: Proportion of Treatment Effect Explained | 4.9 | 24 | Citations (PDF) |
| 57 | Neutrophils induce paracrine telomere dysfunction and senescence in ROS‐dependent manner | 7.3 | 198 | Citations (PDF) |
| 58 | Urinary Steroid Metabolome Signature Is Associated With Pre-Frailty and Frailty Phenotype in Older Adults | 0.3 | 0 | Citations (PDF) |
| 59 | Global and Spatial Compartmental Interrelationships of Bone Density, Microstructure, Geometry and Biomechanics in the Distal Radius in a Colles’ Fracture Study Using HR-pQCT | 3.8 | 3 | Citations (PDF) |
| 60 | Opportunistic application of phantom-less calibration methods for fracture risk prediction using QCT/FEA | 3.6 | 30 | Citations (PDF) |
| 61 | Impaired Cognitive Performance in Patients With Mild Autonomous Cortisol Secretion | 0.3 | 0 | Citations (PDF) |
| 62 | Impaired Muscle Strength and Performance in Patients With Mild Autonomous Cortisol Secretion | 0.3 | 0 | Citations (PDF) |
| 63 | ST-V-Net: incorporating shape prior into convolutional neural networks for proximal femur segmentation | 3.5 | 22 | Citations (PDF) |
| 64 | Senolytics reduce coronavirus-related mortality in old mice | 36.3 | 303 | Citations (PDF) |
| 65 | Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus | 31.8 | 227 | Citations (PDF) |
| 66 | The role of senolytics in osteoporosis and other skeletal pathologies | 4.7 | 37 | Citations (PDF) |
| 67 | Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism | 13.7 | 221 | Citations (PDF) |
| 68 | LPS-induced premature osteocyte senescence: Implications in inflammatory alveolar bone loss and periodontal disease pathogenesis | 3.4 | 106 | Citations (PDF) |
| 69 | Unsupervised machine learning for the discovery of latent disease clusters and patient subgroups using electronic health records | 3.7 | 122 | Citations (PDF) |
| 70 | Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study | 21.7 | 305 | Citations (PDF) |
| 71 | Comparison of Vertebral and Femoral Strength Between White and Asian Adults Using Finite Element Analysis of Computed Tomography Scans | 4.9 | 12 | Citations (PDF) |
| 72 | Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials | 21.7 | 210 | Citations (PDF) |
| 73 | Osteocyte Cellular Senescence | 4.6 | 49 | Citations (PDF) |
| 74 | Periodontal Disease and Senescent Cells: New Players for an Old Oral Health Problem? | 4.4 | 54 | Citations (PDF) |
| 75 | SAT-176 Epidemiology of Adrenal Tumors: A Population Based Study of 1287 Patients | 0.3 | 3 | Citations (PDF) |
| 76 | Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition | 1.7 | 11 | Citations (PDF) |
| 77 | Determinants of Bone Material Strength and Cortical Porosity in Patients with Type 2 Diabetes Mellitus | 4.0 | 76 | Citations (PDF) |
| 78 | Male mice with elevated C-type natriuretic peptide-dependent guanylyl cyclase-B activity have increased osteoblasts, bone mass and bone strength | 3.4 | 21 | Citations (PDF) |
| 79 | The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers | 4.0 | 32 | Citations (PDF) |
| 80 | The role of cellular senescence in ageing and endocrine disease | 31.8 | 478 | Citations (PDF) |
| 81 | Estrogen Versus FSH Effects on Bone Metabolism: Evidence From Interventional Human Studies | 2.5 | 16 | Citations (PDF) |
| 82 | Posterior single-stepping thresholds are prospectively related to falls in older women | 2.7 | 18 | Citations (PDF) |
| 83 | Targeted Reduction of Senescent Cell Burden Alleviates Focal Radiotherapy-Related Bone Loss | 4.9 | 124 | Citations (PDF) |
| 84 | Biomechanical Computed Tomography analysis (BCT) for clinical assessment of osteoporosis | 4.1 | 124 | Citations (PDF) |
| 85 | Hip load capacity and yield load in men and women of all ages | 3.4 | 14 | Citations (PDF) |
| 86 | Development and Application of Mass Spectroscopy Assays for Nε-(1-Carboxymethyl)-L-Lysine and Pentosidine in Renal Failure and Diabetes | 1.3 | 18 | Citations (PDF) |
| 87 | Accelerated osteocyte senescence and skeletal fragility in mice with type 2 diabetes | 5.4 | 114 | Citations (PDF) |
| 88 | SUN-LB68 Advanced Glycation Endproducts Are Associated With Worse Bone Material Strength in Older Adults With and Without Type 2 Diabetes | 0.3 | 1 | Citations (PDF) |
| 89 | SUN-381 Cortical Porosity Is Associated with Peripheral Small Vessel Disease in Adult Patients with Type 2 Diabetes | 0.3 | 0 | Citations (PDF) |
| 90 | MON-219 Prevalence and Incidence of Fractures in Patients with Adrenal Adenomas: A Population-Based Study of 1003 Patients | 0.3 | 0 | Citations (PDF) |
| 91 | Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease | 9.7 | 1,216 | Citations (PDF) |
| 92 | Cellular senescence in bone | 3.4 | 239 | Citations (PDF) |
| 93 | Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans | 4.9 | 115 | Citations (PDF) |
| 94 | Virtual supersampling as post-processing step preserves the trabecular bone morphometry in human peripheral quantitative computed tomography scans | 2.3 | 2 | Citations (PDF) |
| 95 | CURRENT STATE OF SCIENCE ON DRUG THERAPIES FOR OSTEOPOROTIC FRACTURE PREVENTION | 0.1 | 1 | Citations (PDF) |
| 96 | Increased Cortical Porosity and Reduced Trabecular Density Are Not Necessarily Synonymous With Bone Loss and Microstructural Deterioration | 2.0 | 29 | Citations (PDF) |
| 97 | Sex‐specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: A pooled analysis of four clinical trials | 2.3 | 39 | Citations (PDF) |
| 98 | miR-219a-5p Regulates Rorβ During Osteoblast Differentiation and in Age-related Bone Loss | 4.9 | 47 | Citations (PDF) |
| 99 | Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study | 21.7 | 366 | Citations (PDF) |
| 100 | Proceedings of the 2018 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis | 1.1 | 15 | Citations (PDF) |
| 101 | SAT-366 The Impact of Mild Autonomous Cortisol Secretion on Bone Metabolism | 0.3 | 3 | Citations (PDF) |
| 102 | Osteoporosis and Hip Fracture Risk From Routine Computed Tomography Scans: The Fracture, Osteoporosis, and CT Utilization Study (FOCUS) | 4.9 | 110 | Citations (PDF) |
| 103 | Treatment-Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Anti-Resorptive Drugs: A Meta-Regression | 4.9 | 68 | Citations (PDF) |
| 104 | Evaluation of cross-sectional and longitudinal changes in volumetric bone mineral density in postmenopausal women using single- versus dual-energy quantitative computed tomography | 3.4 | 29 | Citations (PDF) |
| 105 | Net ankle quasi-stiffness is influenced by walking speed but not age for older adult women | 1.3 | 24 | Citations (PDF) |
| 106 | The trabecular effect: A population-based longitudinal study on age and sex differences in bone mineral density and vertebral load bearing capacity | 1.2 | 21 | Citations (PDF) |
| 107 | Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis | 4.0 | 121 | Citations (PDF) |
| 108 | Validation of a novel, rapid, high precision sclerostin assay not confounded by sclerostin fragments | 3.4 | 16 | Citations (PDF) |
| 109 | Regulation of Bone Metabolism by Sex Steroids | 6.6 | 300 | Citations (PDF) |
| 110 | Advancing the Science of Healthcare Service Delivery | 2.5 | 4 | Citations (PDF) |
| 111 | Aging, Obesity, and the Incidence of Diverticulitis: A Population-Based Study | 3.7 | 47 | Citations (PDF) |
| 112 | The relationships between compensatory stepping thresholds and measures of gait, standing postural control, strength, and balance confidence in older women | 1.3 | 27 | Citations (PDF) |
| 113 | Factors associated with proximal femur fracture determined in a large cadaveric cohort | 3.4 | 25 | Citations (PDF) |
| 114 | Osteoprotection Through the Deletion of the Transcription Factor Rorβ in Mice | 4.9 | 27 | Citations (PDF) |
| 115 | Senolytics improve physical function and increase lifespan in old age | 33.0 | 2,091 | Citations (PDF) |
| 116 | Sympathetic β1-adrenergic signaling contributes to regulation of human bone metabolism | 10.6 | 120 | Citations (PDF) |
| 117 | Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis | 4.4 | 83 | Citations (PDF) |
| 118 | The comparability of HR-pQCT bone measurements is improved by scanning anatomically standardized regions | 4.1 | 45 | Citations (PDF) |
| 119 | Clinical, cellular, microscopic, and ultrastructural studies of a case of fibrogenesis imperfecta ossium | 13.9 | 6 | Citations (PDF) |
| 120 | Hormonal and systemic regulation of sclerostin | 3.4 | 74 | Citations (PDF) |
| 121 | The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation | 4.1 | 18 | Citations (PDF) |
| 122 | New hope for symptom management during natural and iatrogenic menopause
transitions† | 2.5 | 6 | Citations (PDF) |
| 123 | Targeting cellular senescence prevents age-related bone loss in mice | 33.0 | 1,084 | Citations (PDF) |
| 124 | Diverticulitis is Associated with Increased Abdominal Visceral and Subcutaneous Fat and Muscle Mass: A Population-Based Study | 0.9 | 1 | Citations (PDF) |
| 125 | Fracture Incidence and Characteristics in Young Adults Aged 18 to 49 Years: A Population-Based Study | 4.9 | 74 | Citations (PDF) |
| 126 | The circumstances, orientations, and impact locations of falls in community-dwelling older women | 3.4 | 100 | Citations (PDF) |
| 127 | Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned | 24.6 | 263 | Citations (PDF) |
| 128 | Osteoporosis treatment: recent developments and ongoing challenges | 21.7 | 938 | Citations (PDF) |
| 129 | Circulating osteogenic endothelial progenitor cell counts: new biomarker for the severity of coronary artery disease | 2.2 | 25 | Citations (PDF) |
| 130 | The Limited Clinical Utility of Testosterone, Estradiol, and Sex Hormone Binding Globulin Measurements in the Prediction of Fracture Risk and Bone Loss in Older Men | 4.9 | 41 | Citations (PDF) |
| 131 | Identification of Senescent Cells in the Bone Microenvironment | 4.9 | 513 | Citations (PDF) |
| 132 | Microarchitecture and Peripheral BMD are Impaired in Postmenopausal White Women With Fracture Independently of Total HipT-Score: An International Multicenter Study | 4.9 | 86 | Citations (PDF) |
| 133 | Deletion of Estrogen Receptor Beta in Osteoprogenitor Cells Increases Trabecular but Not Cortical Bone Mass in Female Mice | 4.9 | 39 | Citations (PDF) |
| 134 | Hdac3 Deficiency Increases Marrow Adiposity and Induces Lipid Storage and Glucocorticoid Metabolism in Osteochondroprogenitor Cells | 4.9 | 65 | Citations (PDF) |
| 135 | Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease | 25.2 | 202 | Citations (PDF) |
| 136 | Voxel size dependency, reproducibility and sensitivity of an
in vivo
bone loading estimation algorithm | 3.2 | 24 | Citations (PDF) |
| 137 | Osteoclast TGF-β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation | 4.9 | 85 | Citations (PDF) |
| 138 | Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways | 4.9 | 147 | Citations (PDF) |
| 139 | Comprehensive Assessment of Osteoporosis and Bone Fragility with CT Colonography | 8.7 | 60 | Citations (PDF) |
| 140 | A randomised controlled trial of low-dose aspirin for the prevention of fractures in healthy older people: protocol for the ASPREE-Fracture substudy | 1.6 | 16 | Citations (PDF) |
| 141 | Determinants of bone strength and quality in diabetes mellitus in humans | 3.4 | 176 | Citations (PDF) |
| 142 | The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA | 4.1 | 127 | Citations (PDF) |
| 143 | Statistical Parametric Mapping of HR-pQCT Images: A Tool for Population-Based Local Comparisons of Micro-Scale Bone Features | 3.5 | 10 | Citations (PDF) |
| 144 | Operator variability in scan positioning is a major component of HR-pQCT precision error and is reduced by standardized training | 4.1 | 35 | Citations (PDF) |
| 145 | Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay | 3.9 | 124 | Citations (PDF) |
| 146 | Ability of Circulating Human Hematopoietic Lineage Negative Cells to Support Hematopoiesis | 3.0 | 3 | Citations (PDF) |
| 147 | Regarding “True Gold or Pyrite: A Review of Reference Point Indentation for Assessing Bone Mechanical Properties In Vivo” | 4.9 | 10 | Citations (PDF) |
| 148 | Skeletal changes through the lifespan—from growth to senescence | 31.8 | 173 | Citations (PDF) |
| 149 | Clinical Use of Quantitative Computed Tomography (QCT) of the Hip in the Management of Osteoporosis in Adults: the 2015 ISCD Official Positions—Part I | 1.1 | 121 | Citations (PDF) |
| 150 | Can vitamin D metabolite measurements facilitate a “treat-to-target” paradigm to guide vitamin D supplementation? | 4.1 | 27 | Citations (PDF) |
| 151 | The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs | 6.8 | 2,302 | Citations (PDF) |
| 152 | Global transcriptional profiling using RNA sequencing and DNA methylation patterns in highly enriched mesenchymal cells from young versus elderly women | 3.4 | 39 | Citations (PDF) |
| 153 | Clinical Use of Quantitative Computed Tomography–Based Advanced Techniques in the Management of Osteoporosis in Adults: the 2015 ISCD Official Positions—Part III | 1.1 | 125 | Citations (PDF) |
| 154 | Clinical Use of Quantitative Computed Tomography–Based Finite Element Analysis of the Hip and Spine in the Management of Osteoporosis in Adults: the 2015 ISCD Official Positions—Part II | 1.1 | 133 | Citations (PDF) |
| 155 | Osteogenic monocytes within the coronary circulation and their association with plaque vulnerability in patients with early atherosclerosis | 2.2 | 31 | Citations (PDF) |
| 156 | Effects of Age and Estrogen on Skeletal Gene Expression in Humans as Assessed by RNA Sequencing | 2.3 | 72 | Citations (PDF) |
| 157 | Dissection of Estrogen Receptor Alpha Signaling Pathways in Osteoblasts Using RNA-Sequencing | 2.3 | 23 | Citations (PDF) |
| 158 | Novel anthropomorphic hip phantom corrects systemic interscanner differences in proximal femoral vBMD | 3.1 | 11 | Citations (PDF) |
| 159 | Body Composition During Childhood and Adolescence: Relations to Bone Strength and Microstructure | 4.0 | 51 | Citations (PDF) |
| 160 | Bone Strength and Structural Deficits in Children and Adolescents With a Distal Forearm Fracture Resulting From Mild Trauma | 4.9 | 63 | Citations (PDF) |
| 161 | In Vivo Assessment of Bone Quality in Postmenopausal Women With Type 2 Diabetes | 4.9 | 480 | Citations (PDF) |
| 162 | Mutual Enhancement of Differentiation of Osteoblasts and Osteocytes Occurs Through Direct Cell-Cell Contact | 3.0 | 20 | Citations (PDF) |
| 163 | Osteoporosis detection in postmenopausal women using axial transmission multi-frequency bone ultrasonometer: Clinical findings | 3.7 | 23 | Citations (PDF) |
| 164 | Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial | 27.4 | 49 | Citations (PDF) |
| 165 | Trends in Fracture Incidence: A Population-Based Study Over 20 Years | 4.9 | 350 | Citations (PDF) |
| 166 | The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group | 4.1 | 598 | Citations (PDF) |
| 167 | Cortical Porosity Identifies Women With Osteopenia at Increased Risk for Forearm Fractures | 4.9 | 171 | Citations (PDF) |
| 168 | Effects of Estrogen on Bone mRNA Levels of Sclerostin and Other Genes Relevant to Bone Metabolism in Postmenopausal Women | 4.0 | 83 | Citations (PDF) |
| 169 | Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans | 3.4 | 107 | Citations (PDF) |
| 170 | Diminished Bone Strength Is Observed in Adult Women and Men Who Sustained a Mild Trauma Distal Forearm Fracture During Childhood | 4.9 | 22 | Citations (PDF) |
| 171 | Aromatase Inhibitor-Associated Bone Fractures: A Case-Cohort GWAS and Functional Genomics | 2.5 | 52 | Citations (PDF) |
| 172 | Validation of a CT-Derived Method for Osteoporosis Screening in IBD Patients Undergoing Contrast-Enhanced CT Enterography | 0.7 | 56 | Citations (PDF) |
| 173 | TGF-β Induces Wnt10b in Osteoclasts From Female Mice to Enhance Coupling to Osteoblasts | 2.5 | 84 | Citations (PDF) |
| 174 | Identification of Rorβ targets in cultured osteoblasts and in human bone | 2.1 | 21 | Citations (PDF) |
| 175 | Relationship of adiposity to bone volumetric density and microstructure in men and women across the adult lifespan | 3.4 | 68 | Citations (PDF) |
| 176 | Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors | 3.4 | 84 | Citations (PDF) |
| 177 | Longitudinal changes in lumbar bone mineral density distribution may increase the risk of wedge fractures | 1.2 | 17 | Citations (PDF) |
| 178 | Structural patterns of the proximal femur in relation to age and hip fracture risk in women | 3.4 | 45 | Citations (PDF) |
| 179 | 475 A Novel Means of Assessing Bone Mineral Density and Bone Strength in Patients With Inflammatory Bowel Disease Undergoing CT Enterography | 0.9 | 0 | Citations (PDF) |
| 180 | Effects of Bisphosphonate Treatment on Circulating Osteogenic Endothelial Progenitor Cells in Postmenopausal Women | 3.7 | 31 | Citations (PDF) |
| 181 | Three-dimensional structural analysis of the proximal femur in an age-stratified sample of women | 3.4 | 38 | Citations (PDF) |
| 182 | Pathogenesis of Age-Related Bone Loss in Humans | 3.4 | 206 | Citations (PDF) |
| 183 | Sphingosine 1-Phosphate (S1P) Receptors 1 and 2 Coordinately Induce Mesenchymal Cell Migration through S1P Activation of Complementary Kinase Pathways* | 2.2 | 84 | Citations (PDF) |
| 184 | Coronary endothelial dysfunction is associated with increased risk of osteoporosis in postmenopausal women | 2.2 | 1 | Citations (PDF) |
| 185 | Applications of a New Handheld Reference Point Indentation Instrument Measuring Bone Material Strength | 0.5 | 64 | Citations (PDF) |
| 186 | Effects of Estrogen with Micronized Progesterone on Cortical and Trabecular Bone Mass and Microstructure in Recently Postmenopausal Women | 4.0 | 43 | Citations (PDF) |
| 187 | Improved Fracture Risk Assessment Based on Nonlinear Micro-Finite Element Simulations From HRpQCT Images at the Distal Radius | 4.9 | 43 | Citations (PDF) |
| 188 | A distal forearm fracture in childhood is associated with an increased risk for future fragility fractures in adult men, but not women | 4.9 | 44 | Citations (PDF) |
| 189 | Multicenter precision of cortical and trabecular bone quality measures assessed by high-resolution peripheral quantitative computed tomography | 4.9 | 111 | Citations (PDF) |
| 190 | Sclerostin is expressed in osteoclasts from aged mice and reduces osteoclast‐mediated stimulation of mineralization | 3.0 | 61 | Citations (PDF) |
| 191 | Proximal femoral density distribution and structure in relation to age and hip fracture risk in women | 4.9 | 70 | Citations (PDF) |
| 192 | Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes | 3.9 | 96 | Citations (PDF) |
| 193 | Benefits and Risks of Bisphosphonate Therapy for Osteoporosis | 0.5 | 0 | Citations (PDF) |
| 194 | Isolation and characterization of human osteoblasts from needle biopsies without in vitro culture | 4.1 | 28 | Citations (PDF) |
| 195 | Intestinal Wall Remodeling on CT Enterography May Not Predict Improved Bone Health | 0.7 | 0 | Citations (PDF) |
| 196 | Weekend hospitalization and additional risk of death: An analysis of inpatient data | 1.8 | 280 | Citations (PDF) |
| 197 | TGF-β Mediates Suppression of Adipogenesis by Estradiol through Connective Tissue Growth Factor Induction | 2.5 | 45 | Citations (PDF) |
| 198 | Age-dependent renal cortical microvascular loss in female mice | 3.0 | 37 | Citations (PDF) |
| 199 | Examination of ERα Signaling Pathways in Bone of Mutant Mouse Models Reveals the Importance of ERE-Dependent Signaling | 2.5 | 18 | Citations (PDF) |
| 200 | Patients with an HbA1c in the Prediabetic and Diabetic Range Have Higher Numbers of Circulating Cells with Osteogenic and Endothelial Progenitor Cell Markers | 4.0 | 35 | Citations (PDF) |
| 201 | Insulin-Mediated FFA Suppression Is Associated with Triglyceridemia and Insulin Sensitivity Independent of Adiposity | 4.0 | 21 | Citations (PDF) |
| 202 | Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis | 2.2 | 78 | Citations (PDF) |
| 203 | Relationship of Sympathetic Activity to Bone Microstructure, Turnover, and Plasma Osteopontin Levels in Women | 4.0 | 76 | Citations (PDF) |
| 204 | Better tools for assessing osteoporosis | 10.6 | 20 | Citations (PDF) |
| 205 | Emerging Role of Circulating Calcifying Cells in the Bone-Vascular Axis | 18.0 | 92 | Citations (PDF) |
| 206 | Benefits and Risks of Bisphosphonate Therapy for Osteoporosis | 4.0 | 271 | Citations (PDF) |
| 207 | Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial | 27.4 | 104 | Citations (PDF) |
| 208 | Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selection | 3.4 | 41 | Citations (PDF) |
| 209 | Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin-like growth factor binding protein-2 levels in adult women and men | 4.9 | 99 | Citations (PDF) |
| 210 | Male Osteoporosis | 3.5 | 71 | Citations (PDF) |
| 211 | Estrogen and the skeleton | 8.5 | 843 | Citations (PDF) |
| 212 | Role of Circulating Osteogenic Progenitor Cells in Calcific Aortic Stenosis | 2.3 | 68 | Citations (PDF) |
| 213 | Relationship of age to bone microstructure independent of areal bone mineral density | 4.9 | 123 | Citations (PDF) |
| 214 | Examination of nuclear receptor expression in osteoblasts reveals rorβ as an important regulator of osteogenesis | 4.9 | 39 | Citations (PDF) |
| 215 | Fracture risk in women with breast cancer: A population-based study | 4.9 | 42 | Citations (PDF) |
| 216 | Assessing fracture risk using gradient boosting machine (GBM) models | 4.9 | 63 | Citations (PDF) |
| 217 | A DNA binding mutation in estrogen receptor‐α Leads to suppression of Wnt signaling via β‐catenin destabilization in osteoblasts | 3.0 | 15 | Citations (PDF) |
| 218 | Polyphenol-rich cranberry juice has a neutral effect on endothelial function but decreases the fraction of osteocalcin-expressing endothelial progenitor cells | 3.4 | 69 | Citations (PDF) |
| 219 | The Oxysterol, 27-Hydroxycholesterol, Links Cholesterol Metabolism to Bone Homeostasis Through Its Actions on the Estrogen and Liver X Receptors | 2.5 | 120 | Citations (PDF) |
| 220 | Osteoporosis Update From the 2010 Santa Fe Bone Symposium | 1.1 | 24 | Citations (PDF) |
| 221 | Effects of Physiological Variations in Circulating Insulin Levels on Bone Turnover in Humans | 4.0 | 62 | Citations (PDF) |
| 222 | Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor alpha on bone | 3.4 | 28 | Citations (PDF) |
| 223 | Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women | 3.4 | 80 | Citations (PDF) |
| 224 | Effects of intermittent parathyroid hormone treatment on osteoprogenitor cells in postmenopausal women | 3.4 | 32 | Citations (PDF) |
| 225 | Emerging therapeutic opportunities for skeletal restoration | 79.7 | 149 | Citations (PDF) |
| 226 | Osteoporosis: now and the future | 62.1 | 2,511 | Citations (PDF) |
| 227 | Human Immunodeficiency Virus Envelope Protein Gp120 Induces Proliferation but Not Apoptosis in Osteoblasts at Physiologic Concentrations | 2.3 | 9 | Citations (PDF) |
| 228 | Effects of Suppression of Follicle-Stimulating Hormone Secretion on Bone Resorption Markers in Postmenopausal Women | 0.5 | 0 | Citations (PDF) |
| 229 | Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUSBlood, 2011, 118, 6529-6534 | 4.8 | 72 | Citations (PDF) |
| 230 | Determinants of forearm strength in postmenopausal women | 4.1 | 7 | Citations (PDF) |
| 231 | Towards a diagnostic and therapeutic consensus in male osteoporosis | 4.1 | 120 | Citations (PDF) |
| 232 | Induction of fracture repair by mesenchymal cells derived from human embryonic stem cells or bone marrow | 2.4 | 30 | Citations (PDF) |
| 233 | Regulation of circulating sclerostin levels by sex steroids in women and in men | 4.9 | 216 | Citations (PDF) |
| 234 | Relation of age, gender, and bone mass to circulating sclerostin levels in women and men | 4.9 | 359 | Citations (PDF) |
| 235 | Association of hip strength estimates by finite-element analysis with fractures in women and men | 4.9 | 101 | Citations (PDF) |
| 236 | Fracture risk in men with prostate cancer: A population-based study | 4.9 | 50 | Citations (PDF) |
| 237 | Relationship of testosterone and osteocalcin levels during growth | 4.9 | 75 | Citations (PDF) |
| 238 | Is vitamin D a determinant of muscle mass and strength? | 4.9 | 109 | Citations (PDF) |
| 239 | Wnt10b activates the wnt, notch, and NFκB pathways in u2os osteosarcoma cells | 3.0 | 46 | Citations (PDF) |
| 240 | What Do We Tell Our Patients about Calcium and Vitamin D Supplementation? | 4.0 | 11 | Citations (PDF) |
| 241 | Nonoxidative Free Fatty Acid Disposal Is Greater in Young Women than Men | 4.0 | 50 | Citations (PDF) |
| 242 | Sclerostin levels during growth in children | 4.1 | 72 | Citations (PDF) |
| 243 | Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women | 4.1 | 51 | Citations (PDF) |
| 244 | Age-dependence of femoral strength in white women and men | 4.9 | 131 | Citations (PDF) |
| 245 | The Endogenous Selective Estrogen Receptor Modulator 27-Hydroxycholesterol Is a Negative Regulator of Bone Homeostasis | 4.0 | 0 | Citations (PDF) |
| 246 | Relation of serum serotonin levels to bone density and structural parameters in women | 4.9 | 96 | Citations (PDF) |
| 247 | Effects of chronic estrogen treatment on modulating age-related bone loss in female mice | 4.9 | 50 | Citations (PDF) |
| 248 | Relation of vertebral deformities to bone density, structure, and strength | 4.9 | 98 | Citations (PDF) |
| 249 | Concise Review: Insights from Normal Bone Remodeling and Stem Cell-Based Therapies for Bone Repair | 3.2 | 77 | Citations (PDF) |
| 250 | Fat tissue, aging, and cellular senescence | 6.8 | 996 | Citations (PDF) |
| 251 | Effects of Estrogen and Testosterone on Resting Energy Expenditure in Older Men | 4.0 | 14 | Citations (PDF) |
| 252 | Update on Estrogens and the Skeleton | 2.5 | 0 | Citations (PDF) |
| 253 | Effects of Suppression of Follicle-Stimulating Hormone Secretion on Bone Resorption Markers in Postmenopausal Women | 4.0 | 95 | Citations (PDF) |
| 254 | Update in Male Osteoporosis | 4.0 | 168 | Citations (PDF) |
| 255 | Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells | 2.2 | 72 | Citations (PDF) |
| 256 | Update on Estrogens and the Skeleton | 4.0 | 154 | Citations (PDF) |
| 257 | Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women | 4.0 | 245 | Citations (PDF) |
| 258 | The Endogenous Selective Estrogen Receptor Modulator 27-Hydroxycholesterol Is a Negative Regulator of Bone Homeostasis | 2.5 | 102 | Citations (PDF) |
| 259 | Physiology of Bone Loss | 1.5 | 238 | Citations (PDF) |
| 260 | Circulating osteogenic cells: Characterization and relationship to rates of bone loss in postmenopausal women | 3.4 | 38 | Citations (PDF) |
| 261 | Human embryonic stem cell-derived CD34+ cells function as MSC progenitor cells | 3.4 | 63 | Citations (PDF) |
| 262 | Female reproductive system and bone | 2.8 | 149 | Citations (PDF) |
| 263 | Robust QCT/FEA Models of Proximal Femur Stiffness and Fracture Load During a Sideways Fall on the Hip | 3.5 | 218 | Citations (PDF) |
| 264 | Trabecular bone deficits among Vietnamese immigrants | 4.1 | 1 | Citations (PDF) |
| 265 | Modulators of Androgen and Estrogen Receptor Activity | 1.2 | 8 | Citations (PDF) |
| 266 | Placebo-Controlled Fracture Trials in Osteoporosis — Comment on the Article by Stein and Ray | 34.5 | 3 | Citations (PDF) |
| 267 | Skeletal Consequences of Deletion of Steroid Receptor Coactivator-2/Transcription Intermediary Factor-2 | 2.2 | 22 | Citations (PDF) |
| 268 | Bisphosphonate Associated Osteonecrosis of the Jaw | 2.3 | 185 | Citations (PDF) |
| 269 | Testosterone: More Is Not Always Better | 4.0 | 5 | Citations (PDF) |
| 270 | For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics | 5.3 | 115 | Citations (PDF) |
| 271 | Fatty Acid Metabolism in the Elderly: Effects of Dehydroepiandrosterone and Testosterone Replacement in Hormonally Deficient Men and Women | 4.0 | 36 | Citations (PDF) |
| 272 | Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age‐related decrements | 0.6 | 99 | Citations (PDF) |
| 273 | Bone Structure at the Distal Radius During Adolescent Growth | 4.9 | 256 | Citations (PDF) |
| 274 | Androgens and bone | 1.9 | 224 | Citations (PDF) |
| 275 | Mesenchymal Stem Cells for Bone Repair and Metabolic Bone Diseases | 3.7 | 185 | Citations (PDF) |
| 276 | New selective estrogen and androgen receptor modulators | 3.6 | 42 | Citations (PDF) |
| 277 | Assessing forearm fracture risk in postmenopausal women | 4.1 | 113 | Citations (PDF) |
| 278 | A Population-Based Assessment of Rates of Bone Loss at Multiple Skeletal Sites: Evidence for Substantial Trabecular Bone Loss in Young Adult Women and Men | 4.9 | 481 | Citations (PDF) |
| 279 | Regulation of Bone Turnover by Sex Steroids in Men | 4.9 | 36 | Citations (PDF) |
| 280 | Cost-effective osteoporosis treatment thresholds: the United States perspective | 4.1 | 413 | Citations (PDF) |
| 281 | Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA | 4.1 | 391 | Citations (PDF) |
| 282 | Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women | 4.1 | 198 | Citations (PDF) |
| 283 | Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density | 4.1 | 71 | Citations (PDF) |
| 284 | Skeletal stem/osteoprogenitor cells: Current concepts, alternate hypotheses, and relationship to the bone remodeling compartment | 3.0 | 65 | Citations (PDF) |
| 285 | Loss of ERE binding activity by estrogen receptor‐α alters basal and estrogen‐stimulated bone‐related gene expression by osteoblastic cells | 3.0 | 22 | Citations (PDF) |
| 286 | Serum Biomarker Profile Associated With High Bone Turnover and BMD in Postmenopausal Women | 4.9 | 48 | Citations (PDF) |
| 287 | Fracture Risk in Type 2 Diabetes: Update of a Population-Based Study | 4.9 | 376 | Citations (PDF) |
| 288 | Abdominal Aortic Calcification, BMD, and Bone Microstructure: A Population-Based Study | 4.9 | 50 | Citations (PDF) |
| 289 | Oral Bisphosphonate–Induced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and Treatment | 1.7 | 548 | Citations (PDF) |
| 290 | Osteocalcin Expression by Circulating Endothelial Progenitor Cells in Patients With Coronary Atherosclerosis | 2.3 | 167 | Citations (PDF) |
| 291 | The skeletal response to estrogen is impaired in female but not in male steroid receptor coactivator (SRC)-1 knock out mice | 3.4 | 21 | Citations (PDF) |
| 292 | Use of Renal Function Measurements for Assessing Fracture Risk in Postmenopausal Women | 3.7 | 13 | Citations (PDF) |
| 293 | Bisphosphonates: Mechanism of Action and Role in Clinical Practice | 3.7 | 1,456 | Citations (PDF) |
| 294 | Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease | 24.6 | 781 | Citations (PDF) |
| 295 | Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate | 7.5 | 509 | Citations (PDF) |
| 296 | Bone Growth and Turnover in Progesterone Receptor Knockout Mice | 2.5 | 35 | Citations (PDF) |
| 297 | Osteoporosis in Men | 24.6 | 347 | Citations (PDF) |
| 298 | Insulin-Like Growth Factor Binding Protein-2: A Novel Regulator of Skeletal Gender Differences? | 2.5 | 2 | Citations (PDF) |
| 299 | A Bone Structural Basis for Fracture Risk in Diabetes | 4.0 | 139 | Citations (PDF) |
| 300 | Estrogen Receptor β Isoform-Specific Induction of Transforming Growth Factor β-Inducible Early Gene-1 in Human Osteoblast Cells: An Essential Role for the Activation Function 1 Domain | 2.5 | 45 | Citations (PDF) |
| 301 | Building bone to reverse osteoporosis and repair fractures | 10.6 | 327 | Citations (PDF) |
| 302 | Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo | 4.1 | 18 | Citations (PDF) |
| 303 | Effects of testosterone and estradiol on cutaneous vasodilation during local warming in older men | 3.0 | 14 | Citations (PDF) |
| 304 | Effects of Loss of Classical Estrogen Response Element Signaling on Bone in Male Mice | 2.5 | 30 | Citations (PDF) |
| 305 | Characterization of circulating osteoblast lineage cells in humansBone, 2007, 40, 1370-1377 | 3.4 | 129 | Citations (PDF) |
| 306 | Estrogen and the death of osteoclasts: A fascinating story | 0.4 | 4 | Citations (PDF) |
| 307 | Osteopenia | 34.5 | 114 | Citations (PDF) |
| 308 | Are the Endocrine Society's Clinical Practice Guidelines on Androgen Therapy in Women Misguided? A Commentary-Response | 0.5 | 7 | Citations (PDF) |
| 309 | Effect of Blockade of TNF-α and Interleukin-1 Action on Bone Resorption in Early Postmenopausal Women | 4.9 | 228 | Citations (PDF) |
| 310 | High Serum IGFBP-2 Is Predictive of Increased Bone Turnover in Aging Men and Women | 4.9 | 65 | Citations (PDF) |
| 311 | Contribution of In Vivo Structural Measurements and Load/Strength Ratios to the Determination of Forearm Fracture Risk in Postmenopausal Women | 4.9 | 173 | Citations (PDF) |
| 312 | Structural Determinants of Vertebral Fracture Risk | 4.9 | 187 | Citations (PDF) |
| 313 | Incidence of Primary Hyperparathyroidism in Rochester, Minnesota, 1993-2001: An Update on the Changing Epidemiology of the Disease | 4.9 | 402 | Citations (PDF) |
| 314 | Effects of Sex and Age on Bone Microstructure at the Ultradistal Radius: A Population-Based Noninvasive In Vivo Assessment | 4.9 | 537 | Citations (PDF) |
| 315 | Population-Based Analysis of the Relationship of Whole Bone Strength Indices and Fall-Related Loads to Age- and Sex-Specific Patterns of Hip and Wrist Fractures | 4.9 | 115 | Citations (PDF) |
| 316 | Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline | 4.0 | 292 | Citations (PDF) |
| 317 | DHEA in Elderly Women and DHEA or Testosterone in Elderly Men | 34.5 | 559 | Citations (PDF) |
| 318 | Long-term fracture risk among women with proven endometriosis | 2.9 | 5 | Citations (PDF) |
| 319 | Circulating Cells with Osteogenic Potential | 4.0 | 72 | Citations (PDF) |
| 320 | Age- and Sex-Specific Differences in the Factor of Risk for Vertebral Fracture: A Population-Based Study Using QCT | 4.9 | 140 | Citations (PDF) |
| 321 | Does Reduced Skeletal Loading Account for Age-Related Bone Loss? | 4.9 | 47 | Citations (PDF) |
| 322 | The Classical Estrogen Receptor Transcriptional Pathway: Implications in Human Osteoblasts | 1.4 | 0 | Citations (PDF) |
| 323 | Bone fragility in men - where are we? | 4.1 | 97 | Citations (PDF) |
| 324 | Hormonal and Biochemical Determinants of Trabecular Microstructure at the Ultradistal Radius in Women and Men | 4.0 | 120 | Citations (PDF) |
| 325 | Sex Hormone Binding Globulin: Inhibitor or Facilitator (or Both) of Sex Steroid Action? | 4.0 | 48 | Citations (PDF) |
| 326 | Bone Turnover across the Menopause Transition: Correlations with Inhibins and Follicle-Stimulating Hormone | 4.0 | 104 | Citations (PDF) |
| 327 | Estrogen Receptor Isoform-specific Regulation of the Retinoblastoma-binding Protein 1 (RBBP1) Gene | 2.2 | 25 | Citations (PDF) |
| 328 | Evaluation of a Prediction Model for Long-Term Fracture Risk | 4.9 | 28 | Citations (PDF) |
| 329 | Relationship of Volumetric BMD and Structural Parameters at Different Skeletal Sites to Sex Steroid Levels in Men | 4.9 | 140 | Citations (PDF) |
| 330 | Skeletal Effects of Estrogen Are Mediated by Opposing Actions of Classical and Nonclassical Estrogen Receptor Pathways | 4.9 | 69 | Citations (PDF) |
| 331 | The role of the immune system in the pathophysiology of osteoporosis | 6.4 | 339 | Citations (PDF) |
| 332 | Bone marrow stromal cells express two distinct splice variants of ER-? that are regulated by estrogen | 3.0 | 11 | Citations (PDF) |
| 333 | Contributions of bone density and structure to fracture risk assessment in men and women | 4.1 | 101 | Citations (PDF) |
| 334 | Osteoporosis assessment by whole body region vs. site-specific DXA | 4.1 | 52 | Citations (PDF) |
| 335 | Osteoporosis and Men’s Health (Final 4/07/05) | 4.0 | 0 | Citations (PDF) |
| 336 | A Randomized Placebo-Controlled Trial of Short-Term Graded Transdermal Estradiol in Healthy Gonadotropin-Releasing Hormone Agonist-Suppressed Pre- and Postmenopausal Women: Effects on Serum Markers of Bone Turnover, Insulin-Like Growth Factor-I, and Osteoclastogenic Mediators | 4.0 | 10 | Citations (PDF) |
| 337 | Estrogen Receptor α and β Heterodimers Exert Unique Effects on Estrogen- and Tamoxifen-Dependent Gene Expression in Human U2OS Osteosarcoma Cells | 2.5 | 130 | Citations (PDF) |
| 338 | Magic Bullets to Kill Nasty Osteoclasts | 2.5 | 4 | Citations (PDF) |
| 339 | Relationship of Volumetric Bone Density and Structural Parameters at Different Skeletal Sites to Sex Steroid Levels in Women | 4.0 | 84 | Citations (PDF) |
| 340 | Pathophysiology of Age-Related Bone Loss and Osteoporosis | 3.5 | 314 | Citations (PDF) |
| 341 | Mechanisms of sex steroid effects on bone | 2.1 | 348 | Citations (PDF) |
| 342 | Circulating Osteoblast-Lineage Cells in Humans | 34.5 | 391 | Citations (PDF) |
| 343 | Osteoporosis y la salud masculina (Final 4/7/05) | 4.0 | 0 | Citations (PDF) |
| 344 | Fracture Risk in Monoclonal Gammopathy of Undetermined Significance | 4.9 | 155 | Citations (PDF) |
| 345 | Relationship of Estrogen Receptor Genotypes to Bone Mineral Density and to Rates of Bone Loss in Men | 4.0 | 68 | Citations (PDF) |
| 346 | Native osteoprotegerin gene transfer inhibits the development of murine osteolytic bone disease induced by tumor xenografts | 0.4 | 22 | Citations (PDF) |
| 347 | A Potentially Deleterious Role of IGFBP-2 on Bone Density in Aging Men and Women | 4.9 | 74 | Citations (PDF) |
| 348 | Population-Based Study of Age and Sex Differences in Bone Volumetric Density, Size, Geometry, and Structure at Different Skeletal Sites | 4.9 | 830 | Citations (PDF) |
| 349 | Role of Hormonal Changes in the Pathogenesis of Osteoporosis in Men | 2.8 | 33 | Citations (PDF) |
| 350 | Osteoporosis in Men—Consensus is Premature | 2.8 | 43 | Citations (PDF) |
| 351 | A fragment of the hypophosphatemic factor, MEPE, requires inducible cyclooxygenase-2 to exert potent anabolic effects on normal human marrow osteoblast precursors | 3.0 | 21 | Citations (PDF) |
| 352 | Effects of Loss of Steroid Receptor Coactivator-1 on the Skeletal Response to Estrogen in Mice | 2.5 | 72 | Citations (PDF) |
| 353 | Changes in Runx2/Cbfa1 Expression and Activity During Osteoblastic Differentiation of Human Bone Marrow Stromal Cells | 4.9 | 212 | Citations (PDF) |
| 354 | Fracture Risk After Bilateral Oophorectomy in Elderly Women | 4.9 | 116 | Citations (PDF) |
| 355 | Surrogates for Fracture Endpoints in Clinical Trials | 4.9 | 31 | Citations (PDF) |
| 356 | Role of parathyroid hormone in mediating age-related changes in bone resorption in men | 4.1 | 23 | Citations (PDF) |
| 357 | Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency | 4.1 | 78 | Citations (PDF) |
| 358 | Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone | 3.0 | 206 | Citations (PDF) |
| 359 | Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors ? and ? | 3.0 | 112 | Citations (PDF) |
| 360 | Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ER? or ER? | 3.0 | 149 | Citations (PDF) |
| 361 | Fracture Risk Following Bilateral Orchiectomy | 4.2 | 133 | Citations (PDF) |
| 362 | The role of estrogens in men and androgens in women | 3.5 | 40 | Citations (PDF) |
| 363 | Estrogen, selective estrogen receptor modulators and now mechanism-specific ligands of the estrogen or androgen receptor? | 11.4 | 10 | Citations (PDF) |
| 364 | Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts | 1.3 | 45 | Citations (PDF) |
| 365 | Incidence of Childhood Distal Forearm Fractures Over 30 Years | 16.5 | 452 | Citations (PDF) |
| 366 | Androgens, Estrogens, and Bone Turnover in Men | 4.0 | 15 | Citations (PDF) |
| 367 | Insulin-Like Growth Factor (IGF)-II/IGF-Binding Proteins in Constitutionally Tall Children | 4.0 | 2 | Citations (PDF) |
| 368 | Effect of estrogen replacement therapy on parathyroid hormone secretion in elderly postmenopausal women | 2.4 | 23 | Citations (PDF) |
| 369 | Role of RANK ligand in mediating increased bone resorption in early postmenopausal women | 10.6 | 375 | Citations (PDF) |
| 370 | Role of RANK ligand in mediating increased bone resorption in early postmenopausal women | 10.6 | 661 | Citations (PDF) |
| 371 | Use of Site-Specific Antibodies to Characterize the Circulating Form of Big Insulin-Like Growth Factor II in Patients with Hepatitis C-Associated Osteosclerosis | 4.0 | 33 | Citations (PDF) |
| 372 | Estrogen and the Male Skeleton | 4.0 | 281 | Citations (PDF) |
| 373 | Effect of EstrogenversusTestosterone on Circulating Osteoprotegerin and Other Cytokine Levels in Normal Elderly Men | 4.0 | 172 | Citations (PDF) |
| 374 | Sex Steroids and the Construction and Conservation of the Adult Skeleton | 24.6 | 1,584 | Citations (PDF) |
| 375 | Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis | 1.3 | 68 | Citations (PDF) |
| 376 | Secondary osteoporosis and the risk of distal forearm fractures in men and women | 3.4 | 40 | Citations (PDF) |
| 377 | Author's Response: Effect of EstrogenVersusTestosterone on Circulating Osteoprotegerin and Other Cytokine Levels in Normal Elderly Men | 4.0 | 1 | Citations (PDF) |
| 378 | The Immunosuppressant Rapamycin, Alone or with Transforming Growth Factor-b, Enhances Osteoclast Differentiation of RAW264.7 Monocyte-Macrophage Cells in the Presence of RANK-Ligand | 2.8 | 59 | Citations (PDF) |
| 379 | Correlates of Osteoprotegerin Levels in Women and Men | 4.1 | 186 | Citations (PDF) |
| 380 | Oestrogen, bones and men: when testosterone just isn't enough | 2.3 | 16 | Citations (PDF) |
| 381 | Role of Low Levels of Endogenous Estrogen in Regulation of Bone Resorption in Late Postmenopausal Women | 4.9 | 193 | Citations (PDF) |
| 382 | Estrogen Receptor Isoform-Specific Induction of Progesterone Receptors in Human Osteoblasts | 4.9 | 44 | Citations (PDF) |
| 383 | Estrogen and the Male Skeleton | 4.0 | 98 | Citations (PDF) |
| 384 | Effect of Estrogen versus Testosterone on Circulating Osteoprotegerin and Other Cytokine Levels in Normal Elderly Men | 4.0 | 61 | Citations (PDF) |
| 385 | Use of Site-Specific Antibodies to Characterize the Circulating Form of Big Insulin-Like Growth Factor II in Patients with Hepatitis C-Associated Osteosclerosis | 4.0 | 12 | Citations (PDF) |
| 386 | Author's Response: Effect of Estrogen Versus Testosterone on Circulating Osteoprotegerin and Other Cytokine Levels in Normal Elderly Men | 4.0 | 1 | Citations (PDF) |
| 387 | Effects of Immunosuppressants on Receptor Activator of NF-κB Ligand and Osteoprotegerin Production by Human Osteoblastic and Coronary Artery Smooth Muscle Cells | 2.1 | 203 | Citations (PDF) |
| 388 | Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women | 3.4 | 257 | Citations (PDF) |
| 389 | Relationship of Serum Sex Steroid Levels to Longitudinal Changes in Bone Density in Young Versus Elderly Men | 4.0 | 479 | Citations (PDF) |
| 390 | Estrogens and Bone Health in Men | 2.8 | 80 | Citations (PDF) |
| 391 | Regulation of osteoclastogenesis and RANK expression by TGF-?1 | 3.0 | 109 | Citations (PDF) |
| 392 | Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform | 3.0 | 76 | Citations (PDF) |
| 393 | Effects of Raloxifene, a Selective Estrogen Receptor Modulator, on Bone Turnover Markers and Serum Sex Steroid and Lipid Levels in Elderly Men | 4.9 | 104 | Citations (PDF) |
| 394 | Leptin Reduces Ovariectomy-Induced Bone Loss in Rats | 2.5 | 277 | Citations (PDF) |
| 395 | Prospective Randomized Study of Effects of Unopposed Estrogen Replacement Therapy on Markers of Coagulation and Inflammation in Postmenopausal Women | 4.0 | 76 | Citations (PDF) |
| 396 | Minireview: The OPG/RANKL/RANK System | 2.5 | 1,278 | Citations (PDF) |
| 397 | Minireview: The OPG/RANKL/RANK System | 2.5 | 360 | Citations (PDF) |
| 398 | Relationship of Serum Sex Steroid Levels to Longitudinal Changes in Bone Density in Young Versus Elderly Men | 4.0 | 136 | Citations (PDF) |
| 399 | Prospective Randomized Study of Effects of Unopposed Estrogen Replacement Therapy on Markers of Coagulation and Inflammation in Postmenopausal Women | 4.0 | 31 | Citations (PDF) |
| 400 | Cytokine-specific induction of the TGF-? inducible early gene (TIEG): Regulation by specific members of the TGF-? family | 3.0 | 41 | Citations (PDF) |
| 401 | Relative Influence of Physical Activity, Muscle Mass and Strength on Bone Density | 4.1 | 117 | Citations (PDF) |
| 402 | Effects of Body Size and Skeletal Site on the Estimated Prevalence of Osteoporosis in Women and Men | 4.1 | 89 | Citations (PDF) |
| 403 | Cross-Sectional Versus Longitudinal Evaluation of Bone Loss in Men and Women | 4.1 | 113 | Citations (PDF) |
| 404 | The Effects of Androgens on Osteoblast Function In Vitro | 3.7 | 5 | Citations (PDF) |
| 405 | Relationship of Intestinal Calcium Absorption to 1,25-Dihydroxyvitamin D [1,25(OH)2 D] Levels in Young Versus Elderly Women: Evidence for Age-Related Intestinal Resistance to 1,25(OH)2 D Action 1 | 4.0 | 117 | Citations (PDF) |
| 406 | The Expression of Osteoprotegerin and RANK Ligand and the Support of Osteoclast Formation by Stromal-Osteoblast Lineage Cells Is Developmentally Regulated**This work was supported by Grant AG-04875 from the National Institute on Aging. | 2.5 | 269 | Citations (PDF) |
| 407 | Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women | 9.1 | 162 | Citations (PDF) |
| 408 | Fractures following thyroidectomy in women: a population-based cohort study | 3.4 | 27 | Citations (PDF) |
| 409 | Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial | 4.2 | 76 | Citations (PDF) |
| 410 | Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men | 10.6 | 700 | Citations (PDF) |
| 411 | The Expression of Osteoprotegerin and RANK Ligand and the Support of Osteoclast Formation by Stromal-Osteoblast Lineage Cells Is Developmentally Regulated | 2.5 | 73 | Citations (PDF) |
| 412 | Immunoradiometric Assay for Intact Human Osteocalcin(1–49) without Cross-Reactivity to Breakdown Products | 1.1 | 9 | Citations (PDF) |
| 413 | Response of Bipotential Human Marrow Stromal Cells to Insulin-Like Growth Factors: Effect on Binding Protein Production, Proliferation, and Commitment to Osteoblasts and Adipocytes1 | 2.5 | 76 | Citations (PDF) |
| 414 | Effects of Androgens on the Insulin-Like Growth Factor System in an Androgen-Responsive Human Osteoblastic Cell Line | 2.5 | 84 | Citations (PDF) |
| 415 | The Actions and Interactions of Sex Steroids and Growth Factors/Cytokines on the Skeleton | 2.5 | 228 | Citations (PDF) |
| 416 | Estrogen Stimulates Gene Expression and Protein Production of Osteoprotegerin in Human Osteoblastic Cells* | 2.5 | 610 | Citations (PDF) |
| 417 | Gorham–Stout disease (phantom bone) of the shoulder girdle | 1.9 | 13 | Citations (PDF) |
| 418 | Leptin Acts on Human Marrow Stromal Cells to Enhance Differentiation to Osteoblasts and to Inhibit Differentiation to Adipocytes1 | 2.5 | 691 | Citations (PDF) |
| 419 | Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis1 | 2.5 | 721 | Citations (PDF) |
| 420 | Primary Hyperparathyroidism and the Risk of Fracture: A Population-Based Study | 4.9 | 386 | Citations (PDF) |
| 421 | The Anti-Androgen Hydroxyflutamide and Androgens Inhibit Interleukin-6 Production by an Androgen-Responsive Human Osteoblastic Cell Line | 4.9 | 64 | Citations (PDF) |
| 422 | Secondary osteoporosis and the risk of vertebral deformities in women | 3.4 | 63 | Citations (PDF) |
| 423 | Fracture risk after surgery for peptic ulcer disease: a population-based cohort study | 3.4 | 40 | Citations (PDF) |
| 424 | Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells | 3.4 | 595 | Citations (PDF) |
| 425 | Osteoporosis: gender differences and similarities | 1.7 | 42 | Citations (PDF) |
| 426 | Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis | 2.5 | 208 | Citations (PDF) |
| 427 | Response of Bipotential Human Marrow Stromal Cells to Insulin-Like Growth Factors: Effect on Binding Protein Production, Proliferation, and Commitment to Osteoblasts and Adipocytes | 2.5 | 33 | Citations (PDF) |
| 428 | Effects of Androgens on the Insulin-Like Growth Factor System in an Androgen-Responsive Human Osteoblastic Cell Line | 2.5 | 29 | Citations (PDF) |
| 429 | The Actions and Interactions of Sex Steroids and Growth Factors/Cytokines on the Skeleton | 2.5 | 63 | Citations (PDF) |
| 430 | A Unitary Model for Involutional Osteoporosis: Estrogen Deficiency Causes Both Type I and Type II Osteoporosis in Postmenopausal Women and Contributes to Bone Loss in Aging Men | 4.9 | 1,025 | Citations (PDF) |
| 431 | Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line | 3.0 | 53 | Citations (PDF) |
| 432 | Fracture risk among patients with urolithiasis: A population-based cohort study | 5.3 | 144 | Citations (PDF) |
| 433 | Relationship of Serum Sex Steroid Levels and Bone Turnover Markers with Bone Mineral Density in Men and Women: A Key Role for Bioavailable Estrogen1 | 4.0 | 1,045 | Citations (PDF) |
| 434 | Osteoprotegerin Production by Human Osteoblast Lineage Cells Is Stimulated by Vitamin D, Bone Morphogenetic Protein-2, and Cytokines | 2.1 | 287 | Citations (PDF) |
| 435 | Survival after the Diagnosis of Hyperparathyroidism: A Population-based Study11Access the “Journal Club” discussion of this paper at: http://www.elsevier.com/locate/ajmselect/ | 2.0 | 256 | Citations (PDF) |
| 436 | A Defect in Renal Calcium Conservation May Contribute to the Pathogenesis of Postmenopausal Osteoporosis1 | 4.0 | 29 | Citations (PDF) |
| 437 | Effects of the Circadian Variation in Serum Cortisol on Markers of Bone Turnover and Calcium Homeostasis in Normal Postmenopausal Women1 | 4.0 | 81 | Citations (PDF) |
| 438 | Idiopathic Osteoporosis: Is the Osteoblast to Blame?--Author's Response | 4.0 | 1 | Citations (PDF) |
| 439 | Relationship of Serum Sex Steroid Levels and Bone Turnover Markers with Bone Mineral Density in Men and Women: A Key Role for Bioavailable Estrogen | 4.0 | 702 | Citations (PDF) |
| 440 | Idiopathic Osteoporosis: Is the Osteoblast to Blame?—Author’s Response | 4.0 | 0 | Citations (PDF) |
| 441 | Effects of Age and Estrogen Status on Serum Parathyroid Hormone Levels and Biochemical Markers of Bone Turnover in Women: A Population-Based Study1 | 4.0 | 214 | Citations (PDF) |
| 442 | Update on Primary Osteoporosis | 3.7 | 21 | Citations (PDF) |
| 443 | The Rise and Fall of Primary Hyperparathyroidism: A Population-Based Study in Rochester, Minnesota, 1965-1992 | 9.6 | 278 | Citations (PDF) |
| 444 | Idiopathic Osteoporosis—Is the Osteoblast To Blame? | 4.0 | 33 | Citations (PDF) |
| 445 | Update on Primary Osteoporosis | 3.7 | 16 | Citations (PDF) |
| 446 | Genetic Testing in Medullary Thyroid Carcinoma Syndromes: Mutation Types and Clinical Significance | 3.7 | 44 | Citations (PDF) |
| 447 | Hepatitis C-Associated Osteosclerosis: An Unusual Syndrome of Acquired Osteosclerosis in Adults | 2.0 | 31 | Citations (PDF) |
| 448 | Is familial hyperparathyroidism a unique disease? | 1.8 | 32 | Citations (PDF) |
| 449 | Relationship of Bone Turnover to Bone Density and Fractures | 4.9 | 318 | Citations (PDF) |
| 450 | Development and characterization of a conditionally immortalized human osteoblastic cell line stably transfected with the human androgen receptor gene 1997, 66, 542-551 | | 24 | Citations (PDF) |
| 451 | Role of Estrogen Deficiency in Pathogenesis of Secondary Hyperparathyroidism and Increased Bone Resorption in Elderly Women | 0.5 | 2 | Citations (PDF) |
| 452 | Effects of Age and Estrogen Status on Serum Parathyroid Hormone Levels and Biochemical Markers of Bone Turnover in Women: A Population-Based Study | 4.0 | 178 | Citations (PDF) |
| 453 | Idiopathic Osteoporosis--Is the Osteoblast To Blame? | 4.0 | 32 | Citations (PDF) |
| 454 | Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism | 5.3 | 63 | Citations (PDF) |
| 455 | Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. | 4.0 | 162 | Citations (PDF) |
| 456 | Cytokine production in the bone marrow microenvironment: failure to demonstrate estrogen regulation in early postmenopausal women. | 4.0 | 47 | Citations (PDF) |
| 457 | Relationship between body composition and bone mass in women | 4.9 | 301 | Citations (PDF) |
| 458 | Role of biochemical markers in assessment of osteoporosis | 2.0 | 4 | Citations (PDF) |
| 459 | Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause--a clinical research center study. | 4.0 | 117 | Citations (PDF) |
| 460 | Mutations in the RET protooncogene in sporadic pheochromocytomas. | 4.0 | 47 | Citations (PDF) |
| 461 | Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. | 4.0 | 139 | Citations (PDF) |
| 462 | Familial medullary thyroid cancer and prominent corneal nerves: clinical and genetic analysis. | 4.0 | 11 | Citations (PDF) |
| 463 | Treatment Options for Osteoporosis | 3.7 | 19 | Citations (PDF) |
| 464 | Transforming growth factor-beta 1 induces growth inhibition of a human medullary thyroid carcinoma cell line despite an increase in steady state c-myc messenger ribonucleic acid levels. | 2.5 | 26 | Citations (PDF) |
| 465 | Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3. | 4.0 | 65 | Citations (PDF) |
| 466 | Identification of multiple endocrine neoplasia, type 2 gene carriers using linkage analysis and analysis of the RET proto-oncogene. | 4.0 | 37 | Citations (PDF) |
| 467 | Epidemiology and clinical features of osteoporosis in young individuals | 3.4 | 179 | Citations (PDF) |
| 468 | Circulating cytokine levels in osteoporotic and normal women. | 4.0 | 79 | Citations (PDF) |
| 469 | Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women | 4.9 | 100 | Citations (PDF) |
| 470 | Transforming growth factor-beta 1 induces growth inhibition of a human medullary thyroid carcinoma cell line despite an increase in steady state c-myc messenger ribonucleic acid levels | 2.5 | 7 | Citations (PDF) |
| 471 | Circulating cytokine levels in osteoporotic and normal women | 4.0 | 74 | Citations (PDF) |
| 472 | Muscle strength in Osteoporotic versus normal women | 4.1 | 94 | Citations (PDF) |
| 473 | Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. | 4.0 | 122 | Citations (PDF) |
| 474 | Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism | 4.0 | 120 | Citations (PDF) |
| 475 | In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas. | 4.0 | 91 | Citations (PDF) |
| 476 | Clinical Performance of Parathyroid Hormone Immunometric Assays | 3.7 | 77 | Citations (PDF) |
| 477 | Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. | 10.6 | 119 | Citations (PDF) |
| 478 | Parathyroid Hormone–Related Protein and Hypercalcemia Secondary to Massive Mammary Hyperplasia | 34.5 | 118 | Citations (PDF) |
| 479 | Parathyroid Hormone-Related Peptide in Lactation and in Umbilical Cord Blood | 3.7 | 68 | Citations (PDF) |
| 480 | Nucleotide sequence of cloned cDNAs encoding chicken preproparathyroid hormone | 4.9 | 55 | Citations (PDF) |
| 481 | Autoimmune Hemolytic Anemia With Both Cold and Warm Autoantibodies | 16.5 | 4 | Citations (PDF) |
| 482 | .beta.-Lactamase proceeds via an acyl-enzyme intermediate. Interaction of the Escherichia coli RTEM enzyme with cefoxitin | 2.4 | 242 | Citations (PDF) |
| 483 | Modulation of fracture healing by the transient accumulation of senescent cells | 0.7 | 66 | Citations (PDF) |
| 484 | Title is missing! 0 | | 3 | Citations (PDF) |
| 485 | Advances in the management of osteoporosis | 0.2 | 44 | Citations (PDF) |
| 486 | Global but not myeloid lineage-directed Girk3 deletion increases bone mass in female mice | 2.0 | 0 | Citations (PDF) |
| 487 | Body mass index and subsequent fracture risk: a meta-analysis to update FRAX | 4.9 | 17 | Citations (PDF) |
| 488 | Improved prediction of hip fracture using multi-faceted biomechanical computed tomography | 4.9 | 2 | Citations (PDF) |
| 489 | SkinspanTM: A Healthy Longevity Framework for Skin Aging | 3.7 | 2 | Citations (PDF) |
| 490 | Senolytic Treatment Improves Responsiveness to Mechanical Loading in the Skeleton of Aged Mice | 4.4 | 0 | Citations (PDF) |
| 491 | Beyond Structure: The Interplay of Bone and Brain During Alzheimer's Disease | 0.1 | 1 | Citations (PDF) |
| 492 | Aged murine bone marrow myeloid and mesenchymal cells develop unique senescence phenotypes | 10.6 | 2 | Citations (PDF) |
| 493 | 3 months of romosozumab: a pragmatic clinical solution | 21.7 | 1 | Citations (PDF) |
| 494 | MicroRNA networks associated with skeletal aging and WNT pathway modulation | 2.8 | 0 | Citations (PDF) |
